Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD® in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

NCT01829347 is registered in ClinicalTrials.gov with Vital Therapies, Inc. as lead sponsor.

NCT NCT01829347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01829347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Multicenter, Controlled Study to Assess Safety and Efficacy of ELAD® in Subjects With Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure
Lead sponsor
Vital Therapies, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2014
Completion date
September 30, 2018
Enrollment
18 (actual)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

severe acute alcoholic hepatitis